BIOTINIDASE - NEONATAL SCREENING - ANVISA Registration 10298910092
Access comprehensive regulatory information for BIOTINIDASE - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10298910092 and manufactured by manufacturer not specified. The registration is held by REVVITY DO BRASIL LTDA with validity until Jul 14, 2033.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including INTERNACIONAL CIENTÍFICA LTDA, WALLAC OY, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10298910092
25351244682200877
00351210000124
Company Information
Dates and Status
Jul 14, 2008
14/07/2033
09/18/2025 19:00:01
BIOTINIDASE - TRIAGEM NEONATAL
Kit NeoLISA® BioQ
INTERNACIONAL CIENTÍFICA LTDA
80173700024
Jun 12, 2017
BIOTINIDASE - TRIAGEM NEONATAL
GSP NEONATAL BIOTINIDASE KIT
WALLAC OY
10298910122
Mar 31, 2014
BIOTINIDASE - TRIAGEM NEONATAL
GSP NEONATAL BIOTINIDASE KIT
Not specified
10298910122
Mar 31, 2014
BIOTINIDASE - TRIAGEM NEONATAL
KIT NEOLISA BIO
INTERNACIONAL CIENTÍFICA LTDA
80173700004
Jun 26, 2006

